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Summar~ 
Class II major histocompatibility complex (MFIC) molecules present peptides derived from processed 
antigen to antigen-specific CD4-positive T cells. In addition,  class II molecules bind with high 
affinity another class of antigens,  termed superantigens.  T cell stimulation by superantigens depends 
almost exclusively on the V3 segment expressed by the T ceil receptor (TCR). Mapping of the 
superantigen binding site on class II molecules should provide valuable information on how MHC 
and TCR molecules interact. Recombinant mouse I-A class II molecules expressed on transfected 
L cells were analyzed for their ability to bind the toxic shock syndrome toxin 1. Polymorphic 
residues in the ol helices  of both the ol and B chains of I-A contributed  to quantitative  toxin 
binding,  suggesting that the toxin binds to either a combinatorial or a conformational  site on 
class  II MHC molecules. 
T 
oxic  shock  syndrome  toxin  1  (TSST-1) 1 is  one  of a 
number of related molecules termed superantigens that 
share the property of being able to activate polyclonal T ceils 
expressing particular  V3 gene segments (1, 2). This T  cell 
activation requires that the superantigen be presented in as- 
sociation with ceUs bearing class II MHC molecules (1, 3). 
Superantigens are unlike conventional protein antigens. They 
do not require active cellular processing (4, 5), they do not 
occupy the MHC antigen-binding  groove (6,  7),  and their 
presentation  is not restricted by a particular  class II MHC 
molecule (1, 3, 8). Nonetheless, not all class II MHC mole- 
cules are able to bind and present each of the superantigens 
(6-14). TSST-1 binds effectively to the human class II HLA- 
DR but not the HLA-DP molecule (6,  10).  In the mouse, 
avid binding to I-A  b but not to I-A  k has been demonstrated, 
while binding to I-A  a is intermediate (12).  Mapping of the 
site on MHC to which superantigens bind is not yet com- 
plete. For example,  synthetic peptides from the c~ helix of 
the B chain can interfere with the binding of staphylococcal 
enterotoxin A (SEA) (14).  However, the pattern of TSST-1 
binding  to recombinant  human  class  II molecules demon- 
strates that the c~1 domain contains important sequences for 
this  toxin/MHC  interaction  (6). 
1 Abbreviations used in this paper: SE, staphylococcal enterotoxin; TSST-1, 
toxic shock syndrome toxin  1. 
To better map the region of the MHC molecule to which 
TSST-1 binds, a convenient system was developed in which 
an antiserum  to TSST-1 was used to quantitate  the relative 
amount of TSST-1 binding to I-A-positive cell lines. This assay 
was then used to analyze the ability of TSST-1  to bind to 
various wild-type and recombinant class II MHC molecules 
expressed by transfected L cells. 
Materials and Methods 
Cell Lines.  L cell transfectants expressing the wild-type mole- 
cules I-A  b, I-A  d, and I-A  k, and recombinant I-A  b/k were previously 
described (15, 16). The recombinant  molecules are named using 
the convention  ACt'*'~'*AB  ~a to indicate the alldic  origins  of the 
three hypervariable regions (ctHV1, ctHV2, and ctHV3) of the Act 
chain and the allelic origins of the 3 strands and ct hdix, respec- 
tively, of the A/~ chain. In the AB chain, amino acids 1-49 consti- 
tute the/~ strands and amino acids 50-96 constitute the oe hdix. 
For the Act chain, ctHV1 refers to amino acids 1-38, ctHV2 refers 
to amino acids 3%65, and ctHV3 refers to amino acids 66-end. 
Act  b and Act  k differ at amino acids 11 and 15 in ctHV1; 53, 55, 
56, and 59 in ctHV2; and 6% 70, 75, and 76 in ctHV3. Therefore, 
the ctHV1 differences are in the predicted B strands and the ctHV2 
and ctHV3 differences are in the ct helix. 
FACS  |  Analysis of I-A Surface Expression and of TSST-I Binding 
and Data Reduction.  I-A surface expression was determined  by 
separately incubating L cell transfectants (3  x  10  s) with saturating 
amounts  of 34-5-3 (monoclonal  anti-l-A b,a) (17) and  10-2.16 
(monoclonal anti-I-A k) (18) followed by 50/~I of a 1:50 dilution 
1301  The Journal  of Experimental Medicine ￿9 Volume 175  May 1992  1301-1305 of FITC-conjugated  F(ab')2 fragment  of goat  anti-mouse  Ig 
(Cooper Biomedical,  Malvern, PA). The degree of staining of these 
antibodies has been shown to accurately reflect the level of surface 
I-A expressed  by these transfectants  (15). The nonbinding antibody 
served as a negative control. To determine the degree of TSST-1 
binding, cells were first incubated with 100/zl of TSST-1 (Toxin 
Technology, Madison, WI) at a final concentration of 10/zg/ml, 
followed  by 100/A of a 1:100 dilution of rabbit anti-TSST-1 (Toxin 
Technology), and finally incubated with 50/A of a 1:70 dilution 
of  FITC-conjugated  F(ab')2 fragment  of goat  anti-rabbit  Ig 
(Cooper Biomedical).  These conditions were shown in preliminary 
experiments to be saturating. For controls, the cells were incubated 
with the antiserum and the second antibody, but not the toxin. 
All reagents were diluted in PBS (Mediatech, Washington, DC) 
containing 2% FCS (HyClone Laboratories, Logan, UT) (PBS- 
2%). All incubations were at 4~  for 30 min and cells were washed 
twice with PBS-2% FCS between each reagent and at the end. 
Cells were analyzed  using a FACScan  |  flow cytometer  (Becton  Dick- 
inson & Co., Mountain View, CA). Mean fluorescence  was calcu- 
lated by the C30 program (Becton Dickinson & Co.). The relative 
TSST-1  fluorescence is  defined as  the  ratio  of (TSST-1 fluo- 
rescence- control)/(anti-Ia fluorescence-control). In each experi- 
ment, relative  TSST-1 fluorescence  was corrected  by a constant mul- 
tiplier  so  that the relative TSST-1 fluorescence for one of the 
I-Ab-expressing transfectants (NABB.1F) was 0.5 (range of actual 
values was 0.2-0.65). These corrected values  were used to calculate 
the mean TSST-1 fluorescence  for each recombinant molecule, the 
standard errors of these values, andp values  for all pair-wise  combi- 
nations using the two-tailed student's t test. 
Results  and  Discussion 
The results of a typical experiment are shown in Fig.  1. 
As has been observed (12), there was high level TSST-1 binding 
to  I-A  b,  intermediate binding  to  I-A  a,  and  little  to  no 
binding  of TSST-1  to  I-A  k.  If one calculates  the  relative 
TSST-1 fluorescence, a value is obtained that reflects the ability 
of each MHC molecule to bind the toxin. In this experi- 
ment, the relative TSST-1 fluorescence for I-A  b was 0.44,  for 
I-A  a was 0.22, and for I-A  k was 0.01. This value varied little 
over a threefold range of surface  I-A expression (data not 
shown). The relative TSST-1 fluorescence value does not neces- 
sarily indicate the percentage of I-A molecules that bind the 
toxin. However, it can be used as a measurement of the rela- 
tive binding of the toxin to the different cells. Thus, approx- 
imately twice as many TSST-1 molecules bind to cells ex- 
pressing  I-A  b as  compared with I-A  a,  indicating that the 
interaction of the toxin with I-A  b is  of higher affnity or 
avidity than the interaction of toxin with I-A  a (or I-Ak). The 
lack of TSST-1 binding to I-A  k is not due to a general lack 
of interaction between this class II allele and all exotoxins, 
since SEA,  SEB, SEC, SEE,  and exfoliating toxin all bind 
to I-A  k (7;  and D.  Karp, unpublished observations). 
A panel of L cell transfectants expressing a variety of mu- 
tant I-A molecules derived by the exchange of genomic or 
cDNA sequences between I-A  b and I-A  ~ alleles has been de- 
veloped. These molecules allow the dissection of MHC func- 
tions associated  with particular Ac~ and AB hypervariable 
segments and have proven useful in mapping molecular inter- 
actions within the MHC molecule that control I-A hetero- 
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Figure 1.  Binding  of TSST to ]-A  b, I-A  a, and I-A  k. The transfected  L 
cell line is stained  either for I-A surface  expression (heavy solid line) or for 
the amount  of TSST-1 bound (thin solid line).  The dotted lines are controls 
for I-A (heavy line)  or TSST-1 (thin line)  staining. Fluorescence  intensity 
is expressed in arbitrary  units. The calculated  mean fluorescence  for each 
of the histograms is shown. 
dimer expression and conformation (15, 16). For each of these 
recombinant molecules, several different transfectant lines and 
clones,  each expressing a different level of surface I-A, were 
analyzed to determine the relative TSST-1 fluorescence. A com- 
pilation of the results from five experiments is shown in Fig. 
2. The data reveal, first, that the toxin binds to all transfec- 
tants expressing I-A molecules that contain the c~ helix from 
Aft  b, while it does not appreciably  bind to molecules that 
contain the ot helix from AB  k. In particular, the toxin does 
not  bind  to  the  molecule  Ao~bbbABbk, which  contains  k 
residues in the A3 chain o~ helix but is otherwise I-A  b, even 
though the toxin binds well to the wild-type I-A  b molecule. 
This indicates that polymorphisms in the A3 chain cx helix 
are important for toxin binding, Furthermore, at least in this 
allelic combination, the aUelic origin of the A/3 chain B strands 
does not affect toxin binding (compare Ao~bbbAfl  bb [Fig.  2, 
no.  1] with AoebbbAfl  kb [no.  2]).  In addition to the role of 
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Figure 2.  Relative  TSST-1 binding  to recombinant  I-A 
molecules. The relative  TSST-I fluorescence  was calculated 
as described  using  two to four  different  cell  lines  expressing 
each of the indicated  MHC molecules.  In each  experiment, 
relative TSST-1 fluorescence  was corrected  by a constant 
multiplier so that the relative  TSST-1 fluorescence  for the 
I-Al'-expressing transfectant  (NABB.1F)  was 0.5 (range  of 
actual values was 0.2-0.65). The means and SEs of these 
corrected values as obtained in six separate experiments 
are depicted for each recombinant molecule. For mole- 
cules 1-9, which  bound  the toxin  to some  degree,  n ranged 
from 7 to 17; for the other  molecules,  which  did not bind 
to toxin, n ranged from 2 to 6. The three groups indi- 
cated with either one, two, or three asterisks represent 
three statistically  separate groups  (p <0.05) of toxin  binding 
using a two-tailed student's t test. B and K denote the 
aUelic origins  (1-1-2  ~' or H-2~)  of each of the segments of 
the MHC molecule  in the following  order: c~HV1  ctHV2 
oeHV3:BHV(I+  2)/~HV(3 + 4). The c~HV1 and 3HV(I+ 
2); regions  are in the MHC 3 pleated sheet. The oeHV2, 
~HV3, and BHV(3  +  4) regions are in the two c~ helices. 
MHC 3 chain polymorphic residues, it appears that, as pre- 
viously reported for HLA-DR molecules, residues in the ol 
chain affect toxin binding (6).  Thus,  the molecule Ac~  bbb 
A3  bb (no.  1) binds the toxin better than the molecule Ac~  kkk 
A3  bb (no.  3);  similarly, AotbbbA3  kb (no.  2) binds the toxin 
better than AcckkkA3  kb (no. 4; p <0.005 for cell line nos.  1 
or 2 vs. 3 or 4). Note that Ac~d'A3  bb (no. 3) and Aot~kA3kb 
(no. 4) bind the toxin similarly ~  >0.40),  demonstrating 
that even when binding is suboptimal, K polymorphisms in 
the ~  chain 3  strands do not influence toxin binding. 
One potential caveat  in  this analysis  is  the use of two 
different antibodies to detect surface I-A expression.  The an- 
tibody 34-5-3 detects all I-A molecules in which the cr helix 
of the A~/chain derives from either the b or d haplotype. 
This antibody has similar overall activity and/or affinity for 
all recombinant MHC molecules containing either of these 
molecular segments (15). The antibody 10-2.16 detects I-A 
molecules in which the c~ helix of the A3 chain derives from 
the k haplotype. Comparisons of the TSST-1 fluorescence be- 
tween cells stained with 34-5-3  and those stained with 10- 
2.16 could be difficult to evaluate. However, 10-2.16 was only 
used to quantitate relative I-A surface expression for cell nos. 
5-7 (Fig. 2). The toxin minimally binds to the I-A molecules 
expressed by these cells. For all the other cells in Fig. 2, 34-5-3 
was used to quantitate relative I-A surface expression.  There- 
fore, all comparisons of relative TSST-1 fluorescence in which 
any toxin binding was observed  always involved the use of 
the 34-5-3 antibody to monitor surface I-A expression.  Fur- 
thermore, use of the antibodies Y3P and 39J to determine 
the levels of cell surface I-A expression  gave the same results 
(data not shown). These antibodies principally detect poly- 
morphisms in the Aoe chain and allow a direct comparison 
of relative TSST-1 fluorescence for MHC molecules composed 
of different A3 chain ol helices. 
To further map the As chain polymorphisms important 
for TSST-1 binding, the relative TSST-1 fluorescence was de- 
termined using transfectants expressing the wild-type A~  b 
chains paired with recombinant Aot chains. The results,  also 
shown in Fig.  2,  were obtained using the antibody 34-5-3 
to determine cell surface I-A expression  as all of these cell 
lines express I-A molecules detected by this antibody. The 
substitution of Ac~  k residues  in  either c~HV1 (no.  7)  or 
otHV3  (no.  5)  has  little or  no effect  on TSST-1 binding 
(p >0.10 for cell line nos. 5 vs. 1 or 2; p >0.30 for cell line 
nos. 7 vs. 1 or 2), whereas the substitution of Ace  k residues 
in oeHV2 (nos.  6 or 8) diminishes toxin binding similar to 
what is obtained with the wild-type Aoe  k chain ~  <0.005 
for cell lines  nos.  6 or 8 vs.  1 or 2; p  <0.05  for cell lines 
nos.  6 or 8 vs. 5 or 7).  Thus, it would appear  that o~HV2 
is the most important of the Ac~ polymorphic segments for 
TSST-1 binding. Nonetheless,  it is also apparent that the pres- 
ence of Ao~  b residues in olHV2 is not sufficient  for TSST-1 
binding as the molecule AolkbkA/~  bb (no.  9) only binds in- 
termediate levels of the toxin and is statistically similar to 
cell lines  nos.  6  (p >0.05)  and 8 ~  >0.20). 
The data indicate that residues  in both MHC surface c~ 
helices contribute to the binding of TSST-1. This could indi- 
cate either that there is one TSST-1 binding site on the MHC 
molecule and that this site is influenced by the combination 
of polymorphic residues in the two MHC o~ hdices, or that 
TSST-1 binds to two independent sites on the MHC mole- 
cule,  one in the c~ hdix of the AB chain and the other in 
the o~ helix of the Ac~ chain. The 65% decrease in relative 
TSST-1 fluorescence when toxin binding to Ac~kA3  b is com- 
pared with binding to AccbA3  b is consistent with either in- 
terpretation. However, if there were two independent sites, 
one would also expect a similar partial decrease in relative 
TSST-1 fluorescence when toxin binding to AoebA~  1' is com- 
pared  with binding to AoebA3L  This  is  not  observed  as 
there  is  essentially  no  detectable  binding  of TSST-1 to 
Ao~bA3  k. Therefore, we conclude that residues  in the two 
helices together define the TSST-1 binding site and that there 
is only one TSST-1 binding site per I-A molecule. 
The data demonstrate that polymorphic residues in the c~ 
helix of A3 are essential  for TSST-1 binding and that high 
level toxin binding is dependent on polymorphisms in both 
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most important ot chain polymorphic region in contributing 
to the TSST-1 binding site, high level toxin binding requires 
the presence of other b polymorphisms in either otHV1 or 
olHV3. The c~HV2 region most likely contributes to a con- 
formational  or  combinatorial  toxin  binding  site  because 
residues in this region interact with the ot helix of class II 
/3 chains (16,  19). Models for class II structure also predict 
the presence of a salt bridge between c~HV3 and the ot helix 
of/3 chains (20, 21), but this bridge does not involve poly- 
morphic residues in either chain except in the case of the mu- 
tant A3 chain expressed by NOD mice (22).  Furthermore, 
functional analyses indicate that the otHV3 region is involved 
in interactions with polymorphisms in the/3 strands of the 
A/3 chain but not the/3 chain's c~ helix (16). Thus, it is most 
likely that TSST-1 binds to I-A at a combinatorial otHV2/ 
/3HV4 site or binds to a conformational site that is controlled 
by this  otHV2//3HV4 interaction. 
Given the overall homology of function between the var- 
ious toxins and the common feature of V/3 preference in the 
stimulation  of T  cells by these toxins,  it is likely that,  for 
each of the superantigens,  the functionally relevant interac- 
tions between superantigens, MHC, and TCR would be anal- 
ogous. Analyses of superantigen binding to MHC molecules, 
however, has not identified a single region of the MHC mol- 
ecule as the locus for all toxin binding.  In a previous study, 
it was shown that DR otl residues but not DP otl residues 
allow TSST-1 binding to human class II MHC molecules (6). 
Others have shown that the binding of SEB, SEC 1, and ex- 
foliating toxin to MHC was insensitive to the substitution 
of alanines throughout the ot helix of the Aot chain (7). Anal- 
ysis of SEA binding to mouse class II molecules has shown 
that  this can be inhibited by a peptide derived from the ot 
helix of the A/3 chain. The abilities of synthetic peptides to 
inhibit SEA or TSST-1 binding to mouse and human cell lines 
was shown to vary with the toxin, the peptide, and the cell 
type (14).  Furthermore,  although  TSST-1  and SEB appear 
to have different binding sites on dass II molecules (9), the 
binding of both toxins can be competed by SEA (23). Most 
recently, it has been shown that SEA (24, 25) and SEE (25) 
binding to HLA-DR molecules depends on residue 81 in the 
DtL/3 chain.  This residue is in/3HV4,  the region of the/3 
chain known to contribute to an interchain interaction with 
the otHV2 segment. 
These reports may suggest that many of the superantigens 
bind to unique and distinct sites on MHC. The data in this 
report suggest an alternate explanation.  That is, the toxins 
may all bind to the same conformationally sensitive region 
of MHC and the specific sites for the individual toxins may 
partially overlap. Consequently, depending on the individual 
toxin, the MHC allele or isotype analyzed, and the affinity 
of the toxin-MHC interaction, toxin binding may appear to 
preferentially depend on sequences in one ot helix or the other, 
and individual  toxins may only partly inhibit  each other's 
binding  to MHC. 
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